A Clinical Study Comparing Safety and Immunogenicity of bOPV of Bilthoven Biologicals

计划入组 1,120 人 · 首次发布于 2016 年 5 月 10 日

Combination Therapy With Two Biologicals

计划入组 16 人 · 首次发布于 2021 年 11 月 26 日

Immunogenicity and Safety Study to Evaluate Different Formulations of GSK Biologicals' Influenza Vaccine GSK576389A

计划入组 2,007 人 · 首次发布于 2007 年 10 月 8 日

Tetanus vaccine (Bilthoven Biologicals)

Poliovirus vaccine oral (Bilthoven Biologicals)

Combination DT-IPV vaccine (Bilthoven Biologicals)

GLAXOSMITHKLINE BIOLOGICALS

France

Abbott Biologicals B.V.

Netherlands

GlaxoSmithKline Biologicals SA

Belgium

SIILTIBCY Receives Positive CHMP Opinion for Tuberculosis Detection in Europe

Shilpa Biologicals Expands ADC Capabilities with New Bioconjugation Facility in India

SteinCares and Shilpa Biologicals Form Strategic Partnership to Expand Biosimilar Access Across Latin America